Search Results - "Mousa, Amr A K"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer by Liu, Wenjie, Mousa, Amr A. K., Hopkins, Austin M., Wu, Yin Fang, Thu, Kelsie L., Campbell, Michael, Lees, Simon J., Ramachandran, Rithwik, Hou, Jinqiang

    Published in ChemMedChem (19-08-2024)
    “…Metastasis is responsible for about 90 % of cancer deaths. Anti‐metastatic drugs, termed as migrastatics, offer a distinctive therapeutic approach to address…”
    Get full text
    Journal Article
  2. 2

    Dihydromyricetin protects against gentamicin-induced nephrotoxicity via upregulation of renal SIRT3 and PAX2 by Matouk, Asmaa I, Awad, Eman M, Mousa, Amr A K, Abdelhafez, Sara M N, Fahmy, Usama A, El-Moselhy, Mohamed A, Abdel-Naim, Ashraf B, Anter, Aliaa

    Published in Life sciences (1973) (01-01-2024)
    “…Gentamicin-induced nephrotoxicity limits its widespread use as an effective antibacterial agent. Oxidative stress, inflammatory cytokines and apoptotic cell…”
    Get full text
    Journal Article
  3. 3

    Front Cover: Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer (ChemMedChem 16/2024) by Liu, Wenjie, Mousa, Amr A. K., Hopkins, Austin M., Wu, Yin Fang, Thu, Kelsie L., Campbell, Michael, Lees, Simon J., Ramachandran, Rithwik, Hou, Jinqiang

    Published in ChemMedChem (19-08-2024)
    “…The Front Cover shows a migrastatic candidate (LPA1 antagonist) that effectively suppresses triple‐negative breast cancer (TNBC) migration and invasion,…”
    Get full text
    Journal Article